|
|
 |
 |
| We need your donations to support our
seed money
grant program
for new research as well as our educational and support activities. |
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
 |
 |
 |
|
1. Study of Parathyroid
Hormone Related Proteins (PTHrP) effects on prostate cancer.
PTHrPs are associated with prostate cancer in the bones.
The various PTHrP related protein segments are studied
to find which segments are responsible for the most
destruction in the bones. This will enable us to develop
diagnostic tests and therapeutic agents related to destruction
of bones by prostate cancer. Two papers have been published
on this work.
Seed money grant: $25,000
Needed
to continue: $30,000
Funding is needed. To help support this project, click
on Donation.
2. Treating prostate cancer with Photodynamic Therapy
(PDT).
Using a photodynamic agent on 4 dogs, we were able to
introduce ultrasound-guided optical fibers into the
prostate gland. Laser light pulses through the fibers
into the gland activated the agent. Microscopic examination
of the treated dogs revealed destruction of prostate
cells only, without any damage to surrounding tissue.
More work is needed.
Seed money grant: $10,000.
Needed
to continue: $50,000.
On hold due to lack of funds. To help support this project,
click on Donation.
3. Adjuvant Immune Therapy with Cryosurgery on rats
Three attempts have been made to apply immune therapy
to a cryosurgery prostate cancer treated model. The
immune therapy components are already FDA approved.
We have confirmed the model and therapy on a small number
of animals, but a larger scale test is required to confirm
the results. With confirmation, we hope to move very
quickly to human studies.
Seed money grant: $13,000.
Needed
to continue: $30,000.
On hold due to lack of funds. To help support this project,
click on Donation.
4. New 13-MTD Study with larger number of mice.
We have done a study with a small number of mice to
demonstrate on a small scale the prevention or suppression
of metastatic cancer to the lymph nodes. A larger study
with 25 mice in the treatment and control arms is needed.
We will assess primary tumor weight and progression
to the bones. The GFP fluorescence technique will be
used to assess metastatic progression. Drs. Jack Geller
and Israel Barken will do this work at AntiCancer.
Seed money grant: $12,500
Needed
to continue: $12,500
Funding is needed. To help support this project, click
on Donation
|
|
|
|
|
|
